Edit
PharmAkea Therapeutics
http://www.pharmakea.com/Last activity: 08.10.2013
Active - Reference to Hans Schambye
Location: United States, California, San Diego
Employees: 11-50
Total raised: $45M
Investors 1
| Date | Name | Website |
| - | Bay City C... | baycitycap... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 07.10.2013 | Series A | $45M | - |
Mentions in press and media 4
| Date | Title | Description |
| 08.10.2013 | PharmAkea Raises $45M For Small Molecule Drugs | San Diego-based biopharmaceuticals developer PharmAkea Therapeutics has raised $45M in funding for development of its small molecule drugs, aimed at trating cancer and fibrotic diseases. The funding included $35M from Celgene Corporation in... |
| 07.10.2013 | PharmAkea Therapeutics Raises Series A Financing | PharmAkea Therapeutics, Inc., a San Diego, CA-based developer of a drug discovery platform to generate and advance novel small-molecule therapies targeting cancer and fibrotic diseases, raised 10m in Series A financing from Bay City Capital... |
| 07.10.2013 | PharmAkea Therapeutics Inks $10M in Series A | SAN DIEGO, CA, Bay City Capital has invested $10 million in a Series A equity financing. In addition, Celgene will also take an equity stake in PharmAkea and will retain an exclusive option to acquire the company. >> Click here for... |
| 07.10.2013 | PharmAkea Gets $35M for Collaboration With Celgene | San Diego-based PharmAkea Therapeutics Inc. is receiving $35 million in a three-year contract with Summit, N.J.-based pharma giant Celgene Corp. The two companies will collaborate on cancer and fibrotic diseases. San Francisco-based Bay Cit... |